SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Memory Disorders D008569 33 associated lipids
Parkinson Disease D010300 53 associated lipids
Urinary Incontinence D014549 4 associated lipids
Reperfusion Injury D015427 65 associated lipids
Glucose Intolerance D018149 13 associated lipids
Alcohol-Related Disorders D019973 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Zhang X et al. Puerarin protects dopaminergic neurons in Parkinson's disease models. 2014 Neuroscience pmid:25218963
Fu R et al. Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis. 2014 Gene pmid:25218235
Kim MH et al. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease. 2014 Planta Med. pmid:25210998
Wang J et al. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer. 2014 Mol Med Rep pmid:25189132
Zhang WG et al. Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells. 2014 Mol Med Rep pmid:25175767
Wang C et al. Puerarin protects against β-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway. 2014 Neurochem. Res. pmid:25173404
Xie N et al. Puerarin protects hippocampal neurons against cell death in pilocarpine-induced seizures through antioxidant and anti-apoptotic mechanisms. 2014 Cell. Mol. Neurobiol. pmid:25151533
Maji AK et al. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. 2014 Nat. Prod. Res. pmid:24980468
Ma JQ et al. Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. 2014 Food Chem. Toxicol. pmid:24975872
Wang C et al. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. 2014 Chin J Nat Med pmid:24969524
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Chen YG et al. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using ¹H NMR spectroscopy and multivariate statistical analysis. 2014 J Pharm Biomed Anal pmid:23746990
Zhu G et al. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. 2014 Phytother Res pmid:23512787
Zhou A et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. 2014 Pharm Dev Technol pmid:23978005
Zhong Y et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. 2014 PLoS ONE pmid:24454919
Bao MH et al. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS. 2014 Can. J. Physiol. Pharmacol. pmid:24708212
Mahdy HM et al. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. 2014 Can. J. Physiol. Pharmacol. pmid:24593790
Wang XC et al. [Effect of chaperone-mediated autophagy in MPP(+) -induced SH-SY5Y cells and interventional effect of puerarin]. 2014 Zhongguo Zhong Yao Za Zhi pmid:24754178
Qu H et al. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24583873
Liao ZG et al. Transport properties of puerarin and effect of extract of Radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models. 2014 Phytother Res pmid:24756954